Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger

Sponsor
Rutgers, The State University of New Jersey (Other)
Overall Status
Completed
CT.gov ID
NCT02579317
Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (NIH)
107
1
2
55
1.9

Study Details

Study Description

Brief Summary

Despite conscious intentions to remain abstinent, persons with substance use disorders often find that negative emotions and environmental cues automatically "trigger" drinking and other substance use. This study aims to test whether activating the baroreflex mechanism can be used "in the moment" to help resist drinking triggers. It consists of 3 phases (Recruitment, Intervention, Follow-up).

Stage 1: Trained research staff conduct a comprehensive clinical interview and questionnaires to assess participant's mood, substance use, and triggers. Participants are paired with a Primary Research Clinician (PRC) who will work with them during the intervention.

Stage 2: Approximately 4 weeks after intake into the Center for Great Expectations Intensive Outpatient program, an 8-week intervention begins. Pre-and post-intervention laboratory sessions occur at Cardiac Neuroscience Laboratory, Center of Alcohol Studies, Piscataway, NJ. Some participants take part in pre- and post-intervention neuroimaging sessions (Rutgers University Brain Imaging Center, Newark, NJ). Participants are randomized into an active intervention or control group after the pre-intervention lab session. They are given an iPhone and trained to use a paced breathing app that is pre-loaded onto the phone. Participants in both groups use their app any time they anticipate or experience a trigger to drink or use drugs. Participants are compensated for their use of the app and the time for participation. To ensure that participants are correctly performing the paced breathing task, their PRC visit with them weekly to provide coaching sessions using a computer-based biofeedback program. During the 4th week, ECG and respiration data are collected. Participants also complete questionnaires about mood and triggers, and provide feedback on the usefulness of the app.

During the lab sessions, participants complete a series of questionnaires and ECG, blood pressure and respiration are collected during four 5-minute tasks (resting baseline, non-resonance breathing, resonance breathing, and visual processing/attention). During the neuroimaging sessions, participants are placed in the scanner for structural scans and four 5-minute tasks (as tasks as previously noted); ECG and blood pressure are recorded.

Stage 3: Participants are re-contacted 1 and 3 months after the intervention to complete questionnaires about their quality of life across multiple domains and the usefulness of the app.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Resonance Breathing
  • Behavioral: Non-Resonance Breathing
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
107 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger
Study Start Date :
Nov 1, 2015
Actual Primary Completion Date :
Mar 1, 2020
Actual Study Completion Date :
Jun 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Resonance Breathing

Breathing is paced to the cardiovascular resonance frequency where heart, respiratory, and brain signals become aligned. This can potentially positively impact cognitive-emotional functioning.

Behavioral: Resonance Breathing
Breathing is paced with a pre-installed iPhone app that includes a visual pacer.

Placebo Comparator: Non-Resonance Breathing

Breathing is paced at a non-resonance frequency. It does not align heart, respiratory, and brain signals, and thus does not impact cognitive-emotional functioning.

Behavioral: Non-Resonance Breathing
Breathing is paced with a pre-installed iPhone app that includes a visual pacer.

Outcome Measures

Primary Outcome Measures

  1. Active Substance Use (self-report questionnaire) [Three Months]

Secondary Outcome Measures

  1. Quality of Life (self-report questionnaire) [Three Months]

    Social support, financial resources, etc.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women over age 18

  • Women diagnosed with substance use disorder

  • Women participating in IOP at Center for Great Expectations, New Brunswick, NJ

Exclusion Criteria:
  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center of Alcohol Studies Piscataway New Jersey United States 08854

Sponsors and Collaborators

  • Rutgers, The State University of New Jersey
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Investigators

  • Principal Investigator: Jennifer Buckman, Ph.D., Center of Alcohol Studies

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Jennifer Buckman, Principal Investigator, Rutgers, The State University of New Jersey
ClinicalTrials.gov Identifier:
NCT02579317
Other Study ID Numbers:
  • 15-015R
  • 1R01AA023667-01
First Posted:
Oct 19, 2015
Last Update Posted:
Mar 28, 2022
Last Verified:
Mar 1, 2022
Keywords provided by Jennifer Buckman, Principal Investigator, Rutgers, The State University of New Jersey
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 28, 2022